Surgical site infections (SSIs) are just one of the many complications that may follow a surgical procedure. A study conducted from 2019-2020 found the rate of SSIs in Medicare and Premier populations to be 2%, with the rate of SSIs in patients who received abdominal surgery at approximately 5...
Abscess: Inflamed tissue surrounding a localized gathering of pus, often caused by infection.
Antimicrobial resistance: The process that occurs when bacteria, fungi, and parasites (microorganisms) change over time and no longer respond to antimicrobial medications. This resistance makes it more difficult to treat infections and increases the risk of spreading diseases that result in severe illness and death.
Antimicrobial stewardship: Collective measures that are taken to slow the evolution of multidrug-resistant organisms.
Cellular/tissue-based products: Products, commonly derived from cadavers or other human and other animal cells, that can aid in closing dehisced surgical wounds by providing a substitute for the skin to act as a barrier while healing.
Dehiscence: The splitting or pulling apart of a surgical wound after it has been closed.
Hematoma: The pooling of blood external to blood vessels.
Microbiome: The skin microbiome describes the regular flora and fauna on the human skin, including bacteria, fungi, viruses, and arthropods. Although normal levels are found on intact skin, the proliferation of microbiotic organisms on a post-operative wound can lead to a surgical site infection.
Negative pressure wound therapy: The use of a sealed wound dressing attached to a gentle vacuum pump. This therapy draws fluid away from the wound and can help manage bioburden levels on a surgical wound, thus reducing the risk of developing a surgical site infection.
Nosocomial infection: An infection or condition that originates or is acquired in a hospital. Surgical site infections are considered to be nosocomial.
Seroma: A buildup of serum, or body fluids, in a wound.
Surgical site infection (SSI): An infection of a surgical wound, tissue, or organ space adjacent to the wound, occurring within 30 days of the procedure without involvement of surgical implants and one year if an implant is involved.
The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, Kestrel Health Information, Inc., its affiliates, or subsidiary companies.
- WoundSource Practice Accelerator's blog
- Log in to post comments
- Printer-friendly version
Recommended for You
April 5th, 2023
October 19th, 2022
Holly Hovan MSN, GERO-BC, APRN, CWOCN-AP
Ideally, most wound care professionals may want to prevent surgical wound dehiscence before it occurs. If clinicians prevent dehiscence, the healing process and, subsequently, the patient's ability to return to normal daily activities is...
May 20th, 2022
By WoundSource Editors
Diabetic foot ulcers (DFUs) are open sores or wounds caused by a combination of factors that include neuropathy (lack of sensation), poor circulation, foot deformities, friction or pressure, trauma, and duration of diabetes with complication risks. DFUs...